相关实验视频
Updated: Sep 10, 2025

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.1K
帕金森病患者需要什么药物?
Kevin McFarthing1, Tiago Fleming Outeiro2,3, Maria Carmo Bastos4
1Parkinson's Research Advocate, Oxford, UK.
Journal of Parkinson's disease
|August 26, 2025
概括
患有帕金森病 (PD) 的人希望个性化药物来控制症状并减缓疾病的进展. 患者的需求,重点是生活质量和方便性,应该指导新的帕金森病治疗方法的开发.
科学领域:
- 神经科学
- 药理学
- 以患者为中心的研究
背景情况:
- 帕金森病 (PD) 是一种复杂的神经疾病,临床表现,病理和进展具有显著的异质性.
- 了解患者的需求对于开发有效的帕金森病治疗至关重要.
研究的目的:
- 探索帕金森病患者药物所需的特性.
- 强调以患者为中心的方法在帕金森病药物开发中的重要性.
主要方法:
- 对患者希望的药物属性的定性分析.
- 对帕金森病的当前和潜在治疗策略的审查,包括症状 (ST) 和疾病修饰 (DMT) 治疗.
主要成果:
- 医疗保险公司优先考虑提供最佳疗效,便利性和负担能力的药物.
- 患者报告的烦症状是治疗干预的关键目标.
- 早期诊断和预症状治疗有望阻止PD的进展.
结论:
- 未来的帕金森病药典应该集中在个性化治疗尾酒上.
- 研究人员与PwP之间的合作对于将药物开发与患者需求协调并改善生活质量至关重要.
- 在帕金森病社区保持希望是非常重要的.
相关概念视频
Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Cholinergic Antagonists: Therapeutic Uses
871
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
871
Antipsychotic Drugs: Therapeutic Uses and Side Effects
380
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
380

